Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

View source ↗

Summary

A pilot study by ProgenaBiome evaluating the role of gut flora in Epidermolysis Bullosa has been withdrawn. The study covered Epidermolysis Bullosa and its subt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProgenaBiome

Snippet

Sponsor: ProgenaBiome | Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Simplex | Status: WITHDRAWN